- Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
-
Jeong S, Oh YH, Ahn JC, Choi S, Park SJ, Kim HJ, Lee G, Son JS, Jang H, Lee DH, Sha M, Chen L, Kim W, Park SM
- KMID: 2557397
- Clin Mol Hepatol.
- 2024 Jul;30(3):487-499.
- doi: 10.3350/cmh.2024.0145
Background/Aims: To determine the association between evolutionary changes in metabolic dysfunction-associated steatotic liver disease (MASLD) status and the risk of hepatocellular carcinoma (HCC) in a nationwide population-based cohort. Methods: Information on... -
- CITED
-
- Close
- SHARE
-
- Close
